Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SJP-0008 Phase I Drug-Drug Interaction Study in Healthy Japanese Adults
jRCT2031210444Phase 1Completed
- Sponsor
- Senju Pharmaceutical Co., Ltd.
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, single-arm trial of SJP-0008 in central retinal artery occlusion (CRAO), sponsored by Senju Pharmaceutical Co., Ltd. Primary endpoint: Plasma concentration of compound(s). Started Nov 2021; status: completed.
02
Drugs
SJP-0008
03
Conditions
central retinal artery occlusion (CRAO)
Beyond the preview
Go deeper on jRCT2031210444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031210444.